Faculty Opinions recommendation of Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study.

2021 ◽  
Author(s):  
Alexander Freiberg
Keyword(s):  
Monoclonal Antibody ◽  
Phase 1 ◽  
Human Monoclonal Antibody ◽  
Healthy Adults ◽  
Phase 1 Study ◽  
Antibody Targeting ◽  
Randomised Controlled

Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults

Vaccine ◽  
2012 ◽  
Vol 30 (50) ◽  
pp. 7315-7320 ◽  
Author(s):  
Nithya Gogtay ◽  
Urmila Thatte ◽  
Nilima Kshirsagar ◽  
Brett Leav ◽  
Deborah Molrine ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Rabies Virus ◽  
Dose Escalation ◽  
Phase 1 ◽  
Human Monoclonal Antibody ◽  
Phase 1 Study

Phase 1 study of IMC-3G3, an IgG1 monoclonal antibody targeting PDGFRα in patients with advanced solid malignancies

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 14617-14617 ◽  
Author(s):  
H. Youssoufian ◽  
R. J. Amato ◽  
C. J. Sweeney ◽  
E. G. Chiorean ◽  
F. Fox ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Igg1 Monoclonal Antibody ◽  
Solid Malignancies ◽  
Antibody Targeting

scholarly journals Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults

PLoS Medicine ◽  
2018 ◽  
Vol 15 (1) ◽  
pp. e1002493 ◽  
Author(s):  
Martin R. Gaudinski ◽  
Emily E. Coates ◽  
Katherine V. Houser ◽  
Grace L. Chen ◽  
Galina Yamshchikov ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Monoclonal Antibody ◽  
Phase 1 ◽  
Human Monoclonal Antibody ◽  
Healthy Adults ◽  
Open Label ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document